Daniel Ranch is a Nephrology physician affiliated with The University of Texas at San Antonio Health Science Center. OpenAlex indexes 28 publications with 488 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7703 Floyd Curl Dr
Msc 7813
San Antonio, TX 782293901
Telephone
210-562-5365Registry record last updated 7 Mar 2023.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- KYOWA KIRIN, INC.Program year20256 payments
- Alexion Pharmaceuticals, Inc.Program year20251 payment
- Novo Nordisk IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
38.1%Calcium channel blocker29.9%Amlodipine Besylate100%Part D<11 patientsAngiotensin receptor blocker (ARB)8.2%Losartan Potassium100%Part D<11 patientsMetabolism & gastrointestinal
35.4%Corticosteroid25.9%Prednisone100%Part D<11 patientsH2 blocker9.5%Famotidine100%Part D<11 patientsAnti-infectives
18.4%Azole Antifungal10.9%Fluconazole100%Part D<11 patientsShort-acting sulfonamides7.5%Sulfamethoxazole-Trimethoprim100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Association Between Donor Derived Cell Free DNA, Donor Specific Antibody, and Rejection in Pediatric Kidney Transplant Recipients
American Journal of Transplantation
2025 - Donor-Derived Cell-Free DNA is Higher in Small Pediatric Transplant Recipients Receiving Kidneys from Obese Donors
American Journal of Transplantation
2025 - Single Dose Basiliximab in a Pediatric Kidney Transplant Recipient: A Case Report
American Journal of Transplantation
2025 - Flow Cytometric Crossmatch for Pre-Transplant Immunologic Risk Assessment in Pediatric Kidney Transplant: STILL Not Necessary in Most Cases
American Journal of Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Marcos Restrepo, MD, MSc
The University of Texas at San Antonio Health Science Center
Robert Brzyski, MD
The University of Texas at San Antonio Health Science Center
Devjit Tripathy, MD
The University of Texas at San Antonio Health Science Center
Robert Svatek, MD
The University of Texas at San Antonio Health Science Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”